A case of gabapentin-induced rhabdomyolysis requiring renal replacement therapy

Hemodial Int. 2017 Jan;21(1):E4-E8. doi: 10.1111/hdi.12458. Epub 2016 Jul 8.

Abstract

Gabapentin is commonly used for controlling convulsions, restless pain syndrome, and pain in diabetic neuropathy. Common side effects include dizziness, somnolence, ataxia, peripheral edema, and confusion; gabapentin-induced rhabdomyolysis is rarely reported. To date, the reported cases of gabapentin-induced rhabdomyolysis have been associated with patients with multiple underlying diseases and assuming multiple medicines for various reasons. In this report, we describe a case of gabapentin-induced rhabdomyolysis in a 32-year-old woman with no medical history. We also review related literature and discuss the possible mechanism and the association with other factors. This case shows that gabapentin can induce rhabdomyolysis in healthy patients and that clinicians must consider the possible association between gabapentin and rhabdomyolysis.

Keywords: Gabapentin; renal replacement therapy; rhabdomyolysis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amines / administration & dosage
  • Amines / adverse effects*
  • Amines / therapeutic use
  • Cyclohexanecarboxylic Acids / administration & dosage
  • Cyclohexanecarboxylic Acids / adverse effects*
  • Cyclohexanecarboxylic Acids / therapeutic use
  • Female
  • Gabapentin
  • Humans
  • Renal Dialysis / adverse effects*
  • Renal Replacement Therapy / adverse effects*
  • Renal Replacement Therapy / methods
  • Rhabdomyolysis / chemically induced*
  • gamma-Aminobutyric Acid / administration & dosage
  • gamma-Aminobutyric Acid / adverse effects*
  • gamma-Aminobutyric Acid / therapeutic use

Substances

  • Amines
  • Cyclohexanecarboxylic Acids
  • gamma-Aminobutyric Acid
  • Gabapentin